Publications & Works

Publication Network
Articles 18
All (18)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (12)
Scopus (13)
TRDizin (3)
Other Publications (1)

1. Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities

Yüce M., Albayrak E., Yontar A. K., Çevik S.
SCIENTIFIC REPORTS , vol.15, no.32066, pp.1-16, 2025 (SCI-Expanded, Scopus)

2. The Oncogenic Role of Holliday Junction Recognition Protein in Hepatocellular Carcinoma

YÜCE M., ALBAYRAK E., ŞİŞLİ İ.
JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , 2025 (Scopus)

3. CRISPR/Cas9 mediated next generation gene therapy in chronic myeloid leukemia

Somuncu M. N., Yildirim M. S., Aydin C., Zamani A. G., Duran T., Albayrak E., et al.
INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY , vol.63, no.1, pp.52-65, 2025 (SCI-Expanded) Sustainable Development

4. Tonsil mesenchymal stem cells-derived exosomes differentially effect the cell proliferation depending on different temperature conditions

YÜCE M., ŞİŞLİ İ., ÇİFTCİOĞLU E., ALBAYRAK E., KIRBAŞ O. K., TAŞLI P. N., et al.
The European Research Journal , vol.10, no.5, pp.501-512, 2024 (TRDizin)

5. Changes in stemness properties of human adenoid-derived mesenchymal stem cells during in vitro aging

Yuce M., Albayrak E., Akgül G., Yağcı N., Tekcan E.
Frontiers in Life Sciences and Related Technologies (Online) , vol.5, no.2, pp.122-129, 2024 (TRDizin)

6. Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model

Yüce M., Albayrak E.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY , vol.196, no.7, pp.4105-4124, 2024 (SCI-Expanded, Scopus)

7. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis

MERİÇ N., Albayrak E., Gulbas Z., Kocabas F.
LEUKEMIA & LYMPHOMA , vol.65, no.2, pp.187-198, 2024 (SCI-Expanded, Scopus)

8. Conditioned media of tonsil derived mesenchymal stem cells shows different rates of cytotoxicity on solid cancer cells

YÜCE M., ALBAYRAK E., GÜMÜŞKAPTAN Ç.
Anatolian Current Medical Journal , vol.5, no.4, pp.503-510, 2023 (TRDizin)

9. CRISPR/Cas9 system in hematopoietic stem cells: Basic research and clinical applications

Albayrak E.
Journal of Experimental and Clinical Medicine (Turkey) , vol.40, no.1, pp.161-170, 2023 (Scopus) Creative Commons License

10. Mesenchymal Stem Cell Applications for the Treatment of COVID-19: Clinical Perspective

Kasaplı B. N., Duran Ş. Y., Geçit T., Albayrak E., Yüce M.
ClinMed International Library , vol.9, 2022 (Peer-Reviewed Journal)

11. BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability

Albayrak E., Akgol S., Turan R. D., Uslu M., Kocabas F.
Journal of Cellular Biochemistry , vol.123, no.12, pp.2009-2029, 2022 (SCI-Expanded, Scopus)

12. Hyperthermia-stimulated tonsil-mesenchymal stromal cells suppress hematological cancer cells through downregulation of IL-6

Yüce M., Albayrak E.
JOURNAL OF CELLULAR BIOCHEMISTRY , vol.123, no.12, pp.1966-1979, 2022 (SCI-Expanded, Scopus) Sustainable Development

13. Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content

Uslu M., Albayrak E., KOCABAŞ F.
INTERNATIONAL IMMUNOPHARMACOLOGY , vol.110, 2022 (SCI-Expanded, Scopus)

14. Small molecule-mediated modulation of ubiquitination and neddylation improves HSC function ex vivo

Albayrak E., Uslu M., Akgol S., Tuysuz E. C., Kocabas F.
Journal of Cellular Physiology , vol.236, no.12, pp.8122-8136, 2021 (SCI-Expanded, Scopus)

15. Development of Small Molecule MEIS Inhibitors that modulate HSC activity

Turan R. D., Albayrak E., Uslu M., Siyah P., Alyazici L. Y., Kalkan B. M., et al.
Scientific Reports , vol.10, no.1, 2020 (SCI-Expanded, Scopus) Creative Commons License

16. Temporal modulation of calcium sensing in hematopoietic stem cells is crucial for proper stem cell expansion and engraftment

Uslu M., Albayrak E., Kocabaş F.
Journal of Cellular Physiology , vol.235, no.12, pp.9644-9666, 2020 (SCI-Expanded, Scopus)

17. c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression

Aksoz M., Albayrak E., Aslan G. S., Turan R. D., Alyazici L. Y., Siyah P., et al.
Current Cancer Drug Targets , vol.19, no.6, pp.479-494, 2019 (SCI-Expanded, Scopus)

18. Emerging roles of meis1 in cardiac regeneration, stem cells and cancer

Aksöz M., Turan R. D., Albayrak E., Kocabaş F.
Current Drug Targets , vol.19, no.2, pp.181-190, 2018 (SCI-Expanded, Scopus) Creative Commons License
Papers Presented at Peer-Reviewed Scientific Conferences 4

1. Comparıson of Mesenchymal Stem Cells Derived from Periapical Cysts And Dental Pulp: An In Vitro Evaluation

Pirimoğlu B., Keskin C., Yüce M., Keskin M., Nuhoğlu Z., Albayrak E., et al.
16.Uluslararası Türk Endodonti Derneği Kongresi, Antalya, Turkey, 25 May 2025, (Summary Text)

2. Kronik Miyeloid Lösemide CRISPR/Cas9 Aracılı Yeni Nesil Gen Tedavisi

SOMUNCU M. N., YILDIRIM S., AYDIN C., ZAMANİ A. G., ALBAYRAK E., KAVAKLI İ. H.
1.ulusal Hematoonkogenetik Kongresi, 25 November 2021, (Summary Text)

3. Lösemi Kök Hücrelerinde MEİS1 İfade Profilinin Belirlenmesi Ve MEİS1 İnhibitörlerin Etkisinin İncelenmesi

MERİÇ N., ALBAYRAK E., KOCABAŞ F., GÜLBAŞ Z.
47.Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.252, (Summary Text)

4. Role of Sialyltransferase Family in Cardiomyocyte and Hematopoietic Stem Cell Function

ALBAYRAK E., KOCABAŞ F.
2nd International Stem Cell Congress, Turkey, 15 October 2015, (Summary Text)
Books 3

1. Natural product–based drug nanodelivery systems in cancertherapy

Yüce M., Albayrak E.
in: Studies in Natural Products Chemistry, Atta-ur-Rahman, Editor, Elsevier Science, Oxford/Amsterdam , Amsterdam, pp.41-104, 2025

2. Therapeutic targeting and HSC proliferation by small molecules and biologicals

Albayrak E., Kocabaş F.
in: Control of Cell Cycle & Cell Proliferation, Rossen Donev, Editor, Elsevier Science, Oxford/Amsterdam , Oxford, pp.425-496, 2023

3. Kara Mürver ve Kanser

Albayrak E., Yüce M., Gümüşkaptan Ç.
in: Kara Mürver: Meyve mi İlaç mı?, Hayrettin Mutlu,Elif Günalan, Editor, Nobel Yayınevi, Ankara, pp.117-146, 2022
Metrics

Publication

25

Publication (WoS)

12

Publication (Scopus)

13

Citation (WoS)

24

H-Index (WoS)

3

Citation (Scopus)

162

H-Index (Scopus)

6

Citation (Scholar)

199

H-Index (Scholar)

6

Project

17

Open Access

3
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING